XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.19.1

Fair value measurements (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis | The fair value of the Company’s financial assets and liabilities measured on a recurring basis were as follows:
|  | March 31, 2019 |  |  | December 31, 2018 |
(U.S. Dollars, in thousands) |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |  |  | Total |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Treasury securities |  | $ | 471 |  |  | $ | — |  |  | $ | — |  |  | $ | 471 |  |  | $ | 490 |
Bone Biologics equity warrants |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Bone Biologics equity securities |  |  | — |  |  |  | 219 |  |  |  | — |  |  |  | 219 |  |  |  | 219 |
eNeura debt security |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 17,820 |
eNeura warrant |  |  | — |  |  |  | — |  |  |  | 491 |  |  |  | 491 |  |  |  | — |
Total |  | $ | 471 |  |  | $ | 219 |  |  | $ | 491 |  |  | $ | 1,181 |  |  | $ | 18,529 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration |  | $ | — |  |  | $ | — |  |  | $ | (18,960 | ) |  | $ | (18,960 | ) |  | $ | (28,560 | )
Deferred compensation plan |  |  | — |  |  |  | (1,254 | ) |  |  | — |  |  |  | (1,254 | ) |  |  | (1,275 | )
Total |  | $ | — |  |  | $ | (1,254 | ) |  | $ | (18,960 | ) |  | $ | (20,214 | ) |  | $ | (29,835 | )
Schedule of Changes in Valuation of Securities | The changes in valuation of these securities for the three months ended March 31, 2019 and 2018 are shown below:
|  | Three Months Ended March 31, |
(U.S. Dollars, in thousands) |  | 2019 |  |  | 2018 |
Bone Biologics equity securities and warrants beginning balance |  | $ | 219 |  |  | $ | 2,768 |
Impact of adoption of ASU 2016-01 recognized in other income, net |  |  | — |  |  |  | 1,629 |
Purchase of additional common stock |  |  | — |  |  |  | 500 |
Bone Biologics equity securities and warrants ending balance |  | $ | 219 |  |  | $ | 4,897 |
Schedule of Reconciliation For Contingent Consideration Measured At Fair Value Using Significant Unobservable Inputs | The following table provides a reconciliation of the beginning and ending balances for the contingent consideration measured at fair value using significant unobservable inputs (Level 3):
(U.S. Dollars, in thousands) |  | 2019 |
Contingent consideration at January 1 |  | $ | 28,560 |
Increase in fair value recognized in operating expenses |  |  | 5,400 |
Payment made |  |  | (15,000 | )
Contingent consideration at March 31 |  | $ | 18,960 |
Fair Value, Inputs, Level 3 [Member] |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Schedule of Reconciliation of Debt Security and Warrant | The following table provides a reconciliation of the beginning and ending balances for the eNeura debt security and warrant measured and reflected in the condensed consolidated balance sheets at fair value using significant unobservable inputs (Level 3):
(U.S. Dollars, in thousands) |  | 2019 |  |  | 2018 |
eNeura debt security and warrant at January 1 |  | $ | 17,820 |  |  | $ | 16,050 |
Gains or losses recorded for the period |  |  |  |  |  |  |  |
Recognized in other comprehensive income (loss) |  |  | (2,593 | ) |  |  | — |
Change in classification of debt security to held to maturity |  |  | (15,227 | ) |  |  | — |
Issuance of warrant as consideration for extension |  |  | 491 |  |  |  |  |
eNeura debt security and warrant at March 31 |  | $ | 491 |  |  | $ | 16,050 |

X
- Definition Changes in valuation of securities. + References No definition available. + Details
Name: | ofix_ChangesInValuationOfSecuritiesTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of held to maturity debt securities and warrant reconciliation. + References No definition available. + Details
Name: | ofix_ScheduleOfHeldToMaturityDebtSecuritiesAndWarrantReconciliationTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19279-110258 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |